Summary
In the presence of the serotonin (5-HT) uptake inhibitor citalopram (2×10−5 M), 5-HT, added to the superfusion medium, diminished the electrically induced 3H-overflow from rat cortex slices prelabelled with 3H-5-HT. A 50% decrease of the 3H-overflow was obtained with 6×10−7 M 5-HT. Of the 5-HT antagonists tested (methysergide, methergoline, methiothepin, cyproheptadine, cinanserin, mianserin, pizotifen), methiothepin (50% at 4.5×10−7 M), methergoline (31% at 10−6 M) and cinanserin (30% at 10−6 M) increased the stimulation-induced 3H-overflow. In some experiments the overflow of endogenous 5-HT was measured simultancously with 3H-overflow. The results were qualitatively and quantitatively very similar, indicating that 3H-overflow can be taken as a reliable measure of 5-HT release. The existence of a functional negative feedback control of 5-HT release mediated by presynaptic autoreceptors was confirmed by analysis of the 3H-overflow per pulse at stimulation frequencies between 0.1 and 50 pulses per second (pps). The 3H-overflow per pulse decreased with increasing stimulus frequency, reaching a low level at 1.6 pps corresponding to 30% of the initial value at 0.1 pps. Methiothepin did not increase the stimulation-induced 3H-overflow at 0.1 pps. The stimulation-induced 5H-overflow at 0.1 pps in the absence of methiothepin was equivalent to that at 1.6 pps in the presence of methiothepin. These results suggest that, under the given experimental conditions, at a stimulation frequency of 0.1 pps the 5-HT concentration in the synaptic cleft drops to very low levels, barely sufficient to induce negative feedback. Among a variety of drugs tested, LSD, dimethyltryptamine, m-chlorophenylpiperazine and clonidine decreased the stimulation-induced 3H-overflow, whereas salbutamol, propranolol, oxprenolol, spiroperidol and haloperidol had no effect. Quipazine, known as a 5-HT agonist, unexpectedly augmented the stimulation-induced 3H-overflow. This effect might be attributable partly to its 5-HT uptake inhibiting component, and also to blockade of presynaptic 5-HT receptors.
Similar content being viewed by others
References
Ahtee L, Sharman DF, Vogt M (1970) Acid metabolites of monoamines in avian brain: effects of probenecid and reserpine. Br J Pharmacol 38:72–85
Baumann PA (1980) Presynaptic serotonin autoreceptors in rat cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol (Suppl) 311:R71
Baumann PA, Koella WP (1980) Feedback control of noradrenaline release as a function of noradrenaline concentration in the synaptic cleft in cortical slices of the rat. Brain Res 189:437–448
Baumann PA, Maître L (1977) Blockade of presynaptic-α-receptors and of amine uptake in the rat brain by the antidepressant mianserin. Naunyn-Schmiedeberg's Arch Pharmacol 300:31–37
Bischoff S, Bittiger H, Krauss J (1981) In vivo 3H-spiperone binding to the rat hippocampal formation: Involvement of dopamine receptors. Eur J Pharmacol (in press)
Bourgoin S, Artaud F, Enjalbert A, Héry F, Glowinski J, Hamon M (1977) Acute changes in central serotonin metabolism induced by the blockade or stimulation of serotonergic receptors during ontogenesis in the rat. J Pharmacol Exp Ther 202:519–531
Cerrito F, Raiteri M (1979) Serotonin-release is modulated by presynaptic autoreceptors. Eur J Pharmacol 57:427–430
Chase TN, Katz RI, Kopin IJ (1969) Release of 3H-serotonin from brain slices. J Neurochem 16:607–615
Christensen AV, Ejalland B, Pedersen V, Danneskjold-Samsoe P, Svendsen O (1977) Pharmacology of a new phtalane (Lu 10-171) with specific 5-HT uptake inhibitory properties. Eur J Pharmacol 41: 153–162
Clineschmidt BV, Totaro JA, Pflueger AB, McGuffin JC (1978) Inhibition of the serotonergic uptake system by MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine). Pharmacol Res Commun 10:219–228
Creese I, Snyder SH (1978) 3H-Spiroperidol labels serotonin receptors in rat cerebral cortex and hippocampus. Eur J Pharmacol 49:201
Dunnett CW (1955) A multiple procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096–1121
Dunnett CW (1964) New tables for multiple comparisons with a control. Biometrics 20:482–491
Farnebo LO (1971) Release of monoamines evoked by field stimulation —Studies on some ionic and metabolic requirements. Acta Physiol Scand (Suppl) 371:19–27
Farnebo LO, Hamberger B (1971a) Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta Physiol Scand (Suppl) 371:35–44
Farnebo LO, Hamberger B (1971b) Drug-induced changes in the release of [3H]-noradrenaline from field stimulated rat iris. Br J Pharmacol 43:97–106
Farnebo LO, Hamberger B (1974) Drug-induced changes in the release of 3H-monoamine from field stimulated rat brain slices. J Pharm Pharmacol 26:642–644
Fillion GMB, Rousselle JC, Fillion M-P, Beaudoin DM, Goiny MR, Deniau JM, Jacob JJ (1978) High-affinity binding of 3H-5-hydroxytryptamine to brain synaptosomal membranes: Comparison with 3H-lysergic acid diethylamide binding. Mol Pharmacol 14:50–59
Fuller RW (1980) Pharmacology of central serotonin neurons. Ann Rev Pharmacol Toxicol 20:111–127
Fuller RW, Snoddy HD, Perry KW, Roush BW, Molloy BB, Bymaster FP, Wong DT (1976) The effects of quipazine on serotonin metabolism in rat brain. Life Sci 18:925–934
Göthert M (1980) Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 314:223–230
Göthert M, Weinheimer G (1979) Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices. Naunyn-Schmiedeberg's Arch Pharmacol 310:93–96
Grabowska M, Antkiewics L, Michaluk J (1974) The influence of quipazine on the turnover rate of serotonin. Biochem Pharmacol 23:3211–3212
Green AR, Youdim MBH, Grahame-Smith DG (1976) Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism. Monoamine oxidase activity and behaviour. Neuropharmacology 15:173–179
Hamon M, Bourgoin S, Jagger J, Glowinski J (1974) Effects of LSD on synthesis and release of 5-HT in rat brain slices. Brain Res 69:265–280
Hamon M, Bourgoin S, Enjalberg A, Bockaert J, Hery F, Ternaux JP, Glowinski J (1976) The effects of quipazine on 5-HT metabolism in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 294: 99–108
Hong E, Sancilio LF, Vargas R, Pardo EG (1969) Similarities between the pharmacological actions of quipazine and serotonin. Eur J Pharmacol 6:274–280
Jacoby JH, Howd RA, Levin MS, Wurtman RJ (1976) Mechanisms by which quipazine, a putative serotonin receptor agonist, alters brain 5-hydroxyindole metabolism. Neuropharmacology 15:529–534
Jenner P, Marsden CD, Thanki CM (1980) Behavioral changes induced by N′N-dimethyltryptamine in rodents. Br J Pharmacol 69:69–80
Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978) Serotonergic component of neuroleptic receptors. Nature 272:168–170
Lowry OR, Rosebrough NJ, Farr AL, Randall EJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275
Middlemiss DN, Blakeborough L, Leather RS (1977) Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptors. Nature 267:289–290
Ortmann R, Radeke E, Delini-Stula A (1980) Interaction of salbutamol with the serotonergic system in rat brain. Naunyn-Schmiedeberg's Arch Pharmacol (Suppl) 311:R280
Ponzio F, Jonsson G (1979) A rapid and simple method for the determination of picogram levels of serotonin in brain tissue using liquid chromatography with electrochemical detection. J Neurochem 32: 129–132
Quock RM, Beal GA, Chan ELF (1976) Quipazine: A serotonergic hyperthermic agent in the rabbit. J Pharm Pharmacol 28:170–172
Rodriguez R, Rojas-Ramirez JA, Drucker-Colin RR (1973) Serotoninlike actions of quipazine on the central nervous system. Eur J Pharmacol 24:164–171
Rokosz-Pelc A, Antkiewicz-Michaluk L, Vetulani J (1980) 5-hydroxytryptamine-like properties of m-chlorophenylpiperazine: Comparison with quipazine J Pharm Pharmacol 32:220–222
Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124
Starke K, Montel H (1973) Involvement of α-receptors in clonidineinduced inhibition of transmitter release from central monoamine neurons. Neuropharmacology 16:1073–1080
Waldmeier PC (1981) Stimulation of central serotonin turnover by β-adrenoceptor agonists. Naunyn-Schmiedeberg's Arch Pharmacol (in press)
Weinstock M, Weiss C, Gitter S (1977) Blockade of 5-hydroxytryptamine receptors in the central nervous system by β-receptor antagonists. Neuropharmacology 16:273–276
Westfall TC (1977) Local regulation of adrenergic neurotransmission. Physiol Rev 57:659–728
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baumann, P.A., Waldmeier, P.C. Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn-Schmiedeberg's Arch. Pharmacol. 317, 36–43 (1981). https://doi.org/10.1007/BF00506254
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00506254